Why Novocure Stock Fell More Than 10% in March
Despite last month's pullback, shares of this medical device company that's aiming to revolutionize cancer treatment are up 126% over the last year.
via FOX BUSINESS NEWS https://fxn.ws/2G67VrS
Why Novocure Stock Fell More Than 10% in March
Despite last month's pullback, shares of this medical device company that's aiming to revolutionize cancer treatment are up 126% over the last year.
via FOX BUSINESS NEWS https://fxn.ws/2G67VrS
No comments:
Post a Comment